Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our opinions or reviews. Learn how we make money.

How to buy Exponent stock | 73.05

Own Exponent stock in just a few minutes.


Fact checked

Exponent, Inc is a consulting services business based in the US. Exponent shares (EXPO) are listed on the NASDAQ and all prices are listed in US Dollars. Exponent employs 1,201 staff and has a trailing 12-month revenue of around USD$385.3 million.

How to buy shares in Exponent

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Exponent. Find the stock by name or ticker symbol: EXPO. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Exponent reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$73.05, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Exponent, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Exponent. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

How has coronavirus impacted Exponent's share price?

Since the stock market crash in March caused by coronavirus, Exponent's share price has had significant negative movement.

Its last market close was USD$73.05, which is 10.01% down on its pre-crash value of USD$81.18 and 25.88% up on the lowest point reached during the March crash when the shares fell as low as USD$58.03.

If you had bought USD$1,000 worth of Exponent shares at the start of February 2020, those shares would have been worth USD$835.24 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth USD$998.59.

Exponent share price

Use our graph to track the performance of EXPO stocks over time.

Exponent shares at a glance

Information last updated 2020-10-21.
Latest market closeUSD$73.05
52-week rangeUSD$58.03 - USD$84.62
50-day moving average USD$74.5909
200-day moving average USD$75.6498
Wall St. target priceUSD$88.5
PE ratio 48.9079
Dividend yield USD$0.76 (1.04%)
Earnings per share (TTM) USD$1.52

Compare trading platforms

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Stocks, Mutual funds, ETFs, Forex
$20 per year
Get a personal advisor when you open an account with at least $50,000.
Stocks, Options, ETFs, Cryptocurrency
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
A free way to invest in stocks, ETFs and crypto.
Stocks, Options, ETFs, Futures
Stocks & ETFs: $1/contract to open, $0 to close, $10 max/leg
Futures: $2.50/contract to open, $0 to close
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, Index funds, ETFs, Futures, Cash
$0 + $0.65/contract, $1 minimum
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
TD Ameritrade
or $25 broker-assisted
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Exponent stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Exponent price performance over time

Historical closes compared with the close of $73.05 from 2020-10-19

1 week (2020-10-22) -1.08%
1 month (2020-09-29) 0.41%
3 months (2020-07-29) -11.26%
6 months (2020-04-29) 2.74%
1 year (2019-10-29) 13.22%
2 years (2018-10-29) 48.93%
3 years (2017-10-27) -2.21%
5 years (2015-10-29) 41.60%

Is Exponent under- or over-valued?

Valuing Exponent stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Exponent's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Exponent's P/E ratio

Exponent's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 49x. In other words, Exponent shares trade at around 49x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Exponent's PEG ratio

Exponent's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.14. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Exponent's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Exponent's EBITDA

Exponent's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$96.7 million.

The EBITDA is a measure of a Exponent's overall financial performance and is widely used to measure a its profitability.

Exponent financials

Revenue TTM USD$385.3 million
Operating margin TTM 23.27%
Gross profit TTM USD$139.2 million
Return on assets TTM 10.84%
Return on equity TTM 24.06%
Profit margin 21.12%
Book value $6.442
Market capitalisation USD$3.8 billion

TTM: trailing 12 months

Shorting Exponent shares

There are currently 1.3 million Exponent shares held short by investors – that's known as Exponent's "short interest". This figure is 44.8% up from 895,451 last month.

There are a few different ways that this level of interest in shorting Exponent shares can be evaluated.

Exponent's "short interest ratio" (SIR)

Exponent's "short interest ratio" (SIR) is the quantity of Exponent shares currently shorted divided by the average quantity of Exponent shares traded daily (recently around 357195.5922865). Exponent's SIR currently stands at 3.63. In other words for every 100,000 Exponent shares traded daily on the market, roughly 3630 shares are currently held short.

However Exponent's short interest can also be evaluated against the total number of Exponent shares, or, against the total number of tradable Exponent shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Exponent's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Exponent shares in existence, roughly 30 shares are currently held short) or 0.0343% of the tradable shares (for every 100,000 tradable Exponent shares, roughly 34 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Exponent.

Find out more about how you can short Exponent stock.

Exponent share dividends


Dividend payout ratio: 42.94% of net profits

Recently Exponent has paid out, on average, around 42.94% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.04% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Exponent shareholders could enjoy a 1.04% return on their shares, in the form of dividend payments. In Exponent's case, that would currently equate to about $0.76 per share.

While Exponent's payout ratio might seem fairly standard, it's worth remembering that Exponent may be investing much of the rest of its net profits in future growth.

Exponent's most recent dividend payout was on 25 September 2020. The latest dividend was paid out to all shareholders who bought their shares by 10 September 2020 (the "ex-dividend date").

Have Exponent's shares ever split?

Exponent's shares were split on a 2:1 basis on 8 June 2018. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Exponent shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Exponent shares which in turn could have impacted Exponent's share price.

Exponent share price volatility

Over the last 12 months, Exponent's shares have ranged in value from as little as $58.03 up to $84.62. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Exponent's is 0.2576. This would suggest that Exponent's shares are less volatile than average (for this exchange).

Exponent overview

Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company worldwide. Its services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, electrical engineering and computer science, human factors, industrial structures, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, statistical and data sciences, thermal sciences, and vehicle analysis. The Environmental and Health segment offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. The company offers approximately 90 different technical disciplines to solve complicated issues facing industry and government. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors of the economy. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. Exponent, Inc. was founded in 1967 and is headquartered in Menlo Park, California.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site